Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/13/1157   
Active ingredient: (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one
Indication: Treatment of follicular lymphoma
Sponsor: Voisin Consulting S.A.R.L.
3 rue des Longs Prés, 92100 Boulogne-Billancourt, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
2/08/2013 Orphan designation EMA/OD/047/13 (2013)4731 of 17/07/2013
13/11/2015 Transfer of orphan designation EMA/OD/047/13/T/01 (2015)8037 of 11/11/2015
17/03/2016 Corrigendum (2016)1717 of 15/03/2016
28/09/2016 Transfer of orphan designation EMA/OD/047/13/T/02 (2016) 6306 of 26/09/2016